{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:33:41Z","timestamp":1791344021820,"version":"4.3.1"},"reference-count":27,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type 1 interferon\u2013producing cells (IPCs), also known as plasmacytoid dendritic cell (DC) precursors, represent the key effectors in antiviral innate immunity and triggers for adaptive immune responses. IPCs play important roles in the pathogenesis of systemic lupus erythematosus (SLE) and in modulating immune responses after hematopoietic stem cell transplantation. Understanding IPC development from hematopoietic progenitor cells (HPCs) may provide critical information in controlling viral infection, autoimmune SLE, and graft-versus-host disease. FLT3-ligand (FLT3-L) represents a key IPC differentiation factor from HPCs. Although hematopoietic cytokines such as interleukin-3 (IL-3), IL-7, stem cell factor (SCF), macrophage\u2013colony-stimulating factor (M-CSF), and granulocyte M-CSF (GM-CSF) promote the expansion of CD34+ HPCs in FLT3-L culture, they strongly inhibit HPC differentiation into IPCs. Here we show that thrombopoietin (TPO) cooperates with FLT3-L, inducing CD34+ HPCs to undergo a 400-fold expansion in cell numbers and to generate more than 6 \u00d7 106 IPCs per 106 CD34+ HPCs within 30 days in culture. IPCs derived from HPCs in FLT3-L\/TPO cultures display blood IPC phenotype and have the capacity to produce large amounts of interferon-\u03b1 (IFN-\u03b1) and to differentiate into mature DCs. This culture system, combined with the use of adult peripheral blood CD34+ HPCs purified from G-CSF\u2013mobilized donors, permits the generation of more than 109 IPCs from a single blood donor.<\/jats:p>","DOI":"10.1182\/blood-2003-09-3058","type":"journal-article","created":{"date-parts":[[2003,12,16]],"date-time":"2003-12-16T01:13:31Z","timestamp":1071537211000},"page":"2547-2553","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":115,"title":["Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors"],"prefix":"10.1182","volume":"103","author":[{"given":"Wei","family":"Chen","sequence":"first","affiliation":[{"name":"From the Cancer Center and the Department of Pediatrics, Division of Hematology, Oncology and Bone Marrow Transplantation, University of Minnesota, Minneapolis; and the Department of Immunobiology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Antonenko","sequence":"additional","affiliation":[{"name":"From the Cancer Center and the Department of Pediatrics, Division of Hematology, Oncology and Bone Marrow Transplantation, University of Minnesota, Minneapolis; and the Department of Immunobiology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Sederstrom","sequence":"additional","affiliation":[{"name":"From the Cancer Center and the Department of Pediatrics, Division of Hematology, Oncology and Bone Marrow Transplantation, University of Minnesota, Minneapolis; and the Department of Immunobiology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Liang","sequence":"additional","affiliation":[{"name":"From the Cancer Center and the Department of Pediatrics, Division of Hematology, Oncology and Bone Marrow Transplantation, University of Minnesota, Minneapolis; and the Department of Immunobiology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa S. H.","family":"Chan","sequence":"additional","affiliation":[{"name":"From the Cancer Center and the Department of Pediatrics, Division of Hematology, Oncology and Bone Marrow Transplantation, University of Minnesota, Minneapolis; and the Department of Immunobiology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Kanzler","sequence":"additional","affiliation":[{"name":"From the Cancer Center and the Department of Pediatrics, Division of Hematology, Oncology and Bone Marrow Transplantation, University of Minnesota, Minneapolis; and the Department of Immunobiology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Blom","sequence":"additional","affiliation":[{"name":"From the Cancer Center and the Department of Pediatrics, Division of Hematology, Oncology and Bone Marrow Transplantation, University of Minnesota, Minneapolis; and the Department of Immunobiology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[{"name":"From the Cancer Center and the Department of Pediatrics, Division of Hematology, Oncology and Bone Marrow Transplantation, University of Minnesota, Minneapolis; and the Department of Immunobiology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"From the Cancer Center and the Department of Pediatrics, Division of Hematology, Oncology and Bone Marrow Transplantation, University of Minnesota, Minneapolis; and the Department of Immunobiology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021221083821700_REF1","doi-asserted-by":"crossref","unstructured":"Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol.2000; 18: 767-811.","DOI":"10.1146\/annurev.immunol.18.1.767"},{"key":"2020021221083821700_REF2","doi-asserted-by":"crossref","unstructured":"Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell. 2001;106: 259-262.","DOI":"10.1016\/S0092-8674(01)00456-1"},{"key":"2020021221083821700_REF3","doi-asserted-by":"crossref","unstructured":"Steinman RM, Nussenzweig MC. Inaugural Article: avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A. 2002;99: 351-358.","DOI":"10.1073\/pnas.231606698"},{"key":"2020021221083821700_REF4","doi-asserted-by":"crossref","unstructured":"Caux C, Massacrier C, Vanbervliet B, et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha, II: functional analysis. Blood. 1997;90: 1458-1470.","DOI":"10.1182\/blood.V90.4.1458"},{"key":"2020021221083821700_REF5","doi-asserted-by":"crossref","unstructured":"Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med.1994;179: 1109-1118.","DOI":"10.1084\/jem.179.4.1109"},{"key":"2020021221083821700_REF6","doi-asserted-by":"crossref","unstructured":"Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med.1994;180: 83-93.","DOI":"10.1084\/jem.180.1.83"},{"key":"2020021221083821700_REF7","unstructured":"Banchereau J, Palucka AK, Dhodapkar M, et al. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res.2001; 61: 6451-6458."},{"key":"2020021221083821700_REF8","doi-asserted-by":"crossref","unstructured":"Kadowaki N, Ho S, Antonenko S, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med.2001;194: 863-869.","DOI":"10.1084\/jem.194.6.863"},{"key":"2020021221083821700_REF9","doi-asserted-by":"crossref","unstructured":"Soumelis V, Scott I, Gheyas F, et al. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood. 2001; 98: 906-912.","DOI":"10.1182\/blood.V98.4.906"},{"key":"2020021221083821700_REF10","doi-asserted-by":"crossref","unstructured":"Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science. 2001;294: 1540-1543.","DOI":"10.1126\/science.1064890"},{"key":"2020021221083821700_REF11","doi-asserted-by":"crossref","unstructured":"Arpinati M, Green CL, Heimfeld S, Heuser JE, Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood. 2000;95: 2484-2490.","DOI":"10.1182\/blood.V95.8.2484"},{"key":"2020021221083821700_REF12","doi-asserted-by":"crossref","unstructured":"Rossi M, Arpinati M, Rondelli D, Anasetti C. Plasmacytoid dendritic cells: do they have a role in immune responses after hematopoietic cell transplantation? Hum Immunol.2002;63: 1194-1200.","DOI":"10.1016\/S0198-8859(02)00758-9"},{"key":"2020021221083821700_REF13","doi-asserted-by":"crossref","unstructured":"Waller EK, Rosenthal H, Jones TW, et al. Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood. 2001;97: 2948-2956.","DOI":"10.1182\/blood.V97.10.2948"},{"key":"2020021221083821700_REF14","doi-asserted-by":"crossref","unstructured":"Blom B, Ho S, Antonenko S, Liu YJ. Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells. J Exp Med.2000;192: 1785-1796.","DOI":"10.1084\/jem.192.12.1785"},{"key":"2020021221083821700_REF15","doi-asserted-by":"crossref","unstructured":"Gilliet M, Boonstra A, Paturel C, et al. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte\/macrophage colony-stimulating factor. J Exp Med.2002;195: 953-958.","DOI":"10.1084\/jem.20020045"},{"key":"2020021221083821700_REF16","doi-asserted-by":"crossref","unstructured":"Maraskovsky E, Brasel K, Teepe M, et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med.1996;184: 1953-1962.","DOI":"10.1084\/jem.184.5.1953"},{"key":"2020021221083821700_REF17","doi-asserted-by":"crossref","unstructured":"Pulendran B, Lingappa J, Kennedy MK, et al. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol.1997;159: 2222-2231.","DOI":"10.4049\/jimmunol.159.5.2222"},{"key":"2020021221083821700_REF18","doi-asserted-by":"crossref","unstructured":"Shurin MR, Pandharipande PP, Zorina TD, et al. FLT3 ligand induces the generation of functionally active dendritic cells in mice. Cell Immunol.1997; 179: 174-184.","DOI":"10.1006\/cimm.1997.1152"},{"key":"2020021221083821700_REF19","doi-asserted-by":"crossref","unstructured":"Pulendran B, Smith JL, Caspary G, et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A. 1999;96: 1036-1041.","DOI":"10.1073\/pnas.96.3.1036"},{"key":"2020021221083821700_REF20","doi-asserted-by":"crossref","unstructured":"Maldonado-Lopez R, De Smedt T, Michel P, et al. CD8\u03b1+ and CD8\u03b1- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med.1999;189: 587-592.","DOI":"10.1084\/jem.189.3.587"},{"key":"2020021221083821700_REF21","doi-asserted-by":"crossref","unstructured":"Pulendran B, Banchereau J, Burkeholder S, et al. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol.2000;165: 566-572.","DOI":"10.4049\/jimmunol.165.1.566"},{"key":"2020021221083821700_REF22","doi-asserted-by":"crossref","unstructured":"Maraskovsky E, Daro E, Roux E, et al. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood. 2000;96: 878-884.","DOI":"10.1182\/blood.V96.3.878"},{"key":"2020021221083821700_REF23","doi-asserted-by":"crossref","unstructured":"Kadowaki N, Antonenko S, Lau JY, Liu YJ. Natural interferon \u03b1\/\u03b2-producing cells link innate and adaptive immunity. J Exp Med.2000;192: 219-226.","DOI":"10.1084\/jem.192.2.219"},{"key":"2020021221083821700_REF24","doi-asserted-by":"crossref","unstructured":"Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon\u2013producing cells in human blood. Science. 1999;284: 1835-1837.","DOI":"10.1126\/science.284.5421.1835"},{"key":"2020021221083821700_REF25","doi-asserted-by":"crossref","unstructured":"Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood. 1995;86: 419-431.","DOI":"10.1182\/blood.V86.2.419.bloodjournal862419"},{"key":"2020021221083821700_REF26","doi-asserted-by":"crossref","unstructured":"Piacibello W, Sanavio F, Garetto L, et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 1997;89: 2644-2653.","DOI":"10.1182\/blood.V89.8.2644"},{"key":"2020021221083821700_REF27","doi-asserted-by":"crossref","unstructured":"Arrighi JF, Hauser C, Chapuis B, Zubler RH, Kindler V. Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(\u2014)CD14(\u2014) and a CD34(\u2014)CD14(+) dendritic cell precursor. Blood. 1999;93: 2244-2252.","DOI":"10.1182\/blood.V93.7.2244"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/7\/2547\/1697043\/zh800704002547.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/7\/2547\/1697043\/zh800704002547.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T16:50:31Z","timestamp":1682614231000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/103\/7\/2547\/18257\/Thrombopoietin-cooperates-with-FLT3ligand-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,1]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,4,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-09-3058","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,1]]}}}